Synthetic Manipulation of the Cancer-Immunity Cycle: CAR-T Cell Therapy

Investigators reviewed CAR T cell design and the mechanisms that drive sustained CAR T cell effector activity and anti-tumor function. They discuss engineering approaches aimed at improving anti-tumor function through a variety of mechanistic interventions for both hematologic and solid tumors.